Subscribe to RSS
Comparing Postpartum Visit Attendance with a Scheduled 2- to 3-Week or 6-Week Visit after DeliveryFunding The project described was supported by the Society of Family Planning and the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), through grant UL1 TR001860 for use of REDCap and statistical support.
26 July 2018
20 September 2018
10 November 2018 (online)
Objective To evaluate whether scheduling a 2- to 3-week versus 6-week postpartum visit results in higher visit attendance.
Study Design We conducted a secondary analysis of a quasi-experimental before–after study to compare postpartum visit attendance after changing routine scheduling of visits from 6 weeks to 2 to 3 weeks after delivery. Secondary outcomes include patient satisfaction and breastfeeding continuation at 3 and 6 months postpartum. We collected postpartum visit information through a chart review and conducted telephonic interviews at 3 and 6 months postpartum to assess satisfaction with visit timing and breastfeeding status. We performed multivariable analyses to assess predictors of visit attendance.
Results Women scheduled at 2 to 3 weeks postpartum demonstrated higher visit attendance (90.2%; 95% confidence interval [CI]: 86.6–93.9%) compared with 6 weeks (81.6%; 95% CI: 76.3–86.2%; p < 0.01). Predictors for visit attendance include postpartum visit timing, age, education, parity, prior miscarriage, and high-risk index pregnancy in multivariate analysis. Scheduling at 2 to 3 weeks postpartum increased visit completion in women who were younger and had lower educational attainment, high-risk index pregnancy, and no prior miscarriages. We found no differences in patient satisfaction or breastfeeding continuation at 3 and 6 months postpartum related to postpartum visit timing.
Conclusion Scheduling a 2- to 3-week postpartum visit is associated with higher attendance.
The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
- 1 ACOG Committee Opinion No. 736: optimizing postpartum care. Obstet Gynecol 2018; 131 (05) e140-e150
- 2 Stumbras K, Rankin K, Caskey R, Haider S, Handler A. Guidelines and interventions related to the postpartum visit for low-risk postpartum women in high and upper middle income countries. Matern Child Health J 2016; 20 (Suppl. 01) 103-116
- 3 Levine LD, Nkonde-Price C, Limaye M, Srinivas SK. Factors associated with postpartum follow-up and persistent hypertension among women with severe preeclampsia. J Perinatol 2016; 36 (12) 1079-1082
- 4 DiBari JN, Yu SM, Chao SM, Lu MC. Use of postpartum care: predictors and barriers. J Pregnancy 2014; 2014: 530769
- 5 Wilcox A, Levi EE, Garrett JM. Predictors of non-attendance to the postpartum follow-up visit. Matern Child Health J 2016; 20 (Suppl. 01) 22-27
- 6 Simmons KB, Edelman AB, Li H, Yanit KE, Jensen JT. Personalized contraceptive assistance and uptake of long-acting, reversible contraceptives by postpartum women: a randomized, controlled trial. Contraception 2013; 88 (01) 45-51
- 7 Tully KP, Stuebe AM, Verbiest SB. The fourth trimester: a critical transition period with unmet maternal health needs. Am J Obstet Gynecol 2017; 217 (01) 37-41
- 8 Henderson V, Stumbras K, Caskey R, Haider S, Rankin K, Handler A. Understanding factors associated with postpartum visit attendance and contraception choices: listening to low-income postpartum women and health care providers. Matern Child Health J 2016; 20 (Suppl. 01) 132-143
- 9 Batra P, Fridman M, Leng M, Gregory KD. Emergency department care in the postpartum period: California births, 2009–2011. Obstet Gynecol 2017; 130 (05) 1073-1081
- 10 Speroff L, Mishell Jr DR. The postpartum visit: it's time for a change in order to optimally initiate contraception. Contraception 2008; 78 (02) 90-98
- 11 Sharif K, Jordan J. The 6-week postnatal visit: are we doing it right?. Br J Hosp Med 1995; 54 (01) 7-10
- 12 Chen MJ, Hou MY, Hsia JK, Cansino CD, Melo J, Creinin MD. Long-acting reversible contraception initiation with a 2- to 3-week compared with a 6-week postpartum visit. Obstet Gynecol 2017; 130 (04) 788-794
- 13 Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42 (02) 377-381
- 14 Tsai PJ, Nakashima L, Yamamoto J, Ngo L, Kaneshiro B. Postpartum follow-up rates before and after the postpartum follow-up initiative at Queen Emma Clinic. Hawaii Med J 2011; 70 (03) 56-59
- 15 Baldwin MK, Hart KD, Rodriguez MI. Predictors for follow-up among postpartum patients enrolled in a clinical trial. Contraception 2018; 98 (03) 228-231
- 16 Bernard C, Wan L, Peipert JF, Madden T. Comparison of an additional early visit to routine postpartum care on initiation of long-acting reversible contraception: a randomized trial. Contraception 2018; 98 (03) 223-227
- 17 Baldwin MK, Edelman AB, Lim JY, Nichols MD, Bednarek PH, Jensen JT. Intrauterine device placement at 3 versus 6 weeks postpartum: a randomized trial. Contraception 2016; 93 (04) 356-363
- 18 Zerden ML, Stuart GS, Charm S, Bryant A, Garrett J, Morse J. Two-week postpartum intrauterine contraception insertion: a study of feasibility, patient acceptability and short-term outcomes. Contraception 2017; 95 (01) 65-70
- 19 Centers for Disease Control and Prevention. Breastfeeding Report Card, 2014. Available at: https://www.cdc.gov/breastfeeding/pdf/2014breastfeedingreportcard.pdf . Accessed October 31, 2017